INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 45 filers reported holding INFINITY PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,968 | +17.4% | 14,100 | -10.8% | 0.00% | – |
| Q1 2023 | $2,528 | -89.9% | 15,800 | -65.5% | 0.00% | – |
| Q4 2022 | $25,000 | -67.1% | 45,800 | -28.1% | 0.00% | – |
| Q3 2022 | $76,000 | +72.7% | 63,720 | -7.5% | 0.00% | – |
| Q2 2022 | $44,000 | -48.8% | 68,920 | -8.6% | 0.00% | – |
| Q1 2022 | $86,000 | -50.3% | 75,405 | -1.8% | 0.00% | – |
| Q4 2021 | $173,000 | -61.0% | 76,795 | -40.9% | 0.00% | – |
| Q3 2021 | $444,000 | +48.5% | 129,900 | +30.0% | 0.00% | – |
| Q2 2021 | $299,000 | 0.0% | 99,900 | +7.9% | 0.00% | – |
| Q1 2021 | $299,000 | +754.3% | 92,600 | +464.6% | 0.00% | – |
| Q4 2020 | $35,000 | +84.2% | 16,400 | 0.0% | 0.00% | – |
| Q3 2020 | $19,000 | +26.7% | 16,400 | 0.0% | 0.00% | – |
| Q2 2020 | $15,000 | +25.0% | 16,400 | +16.3% | 0.00% | – |
| Q1 2020 | $12,000 | -92.7% | 14,100 | -82.0% | 0.00% | – |
| Q1 2018 | $164,000 | +3.1% | 78,220 | +0.0% | 0.00% | – |
| Q4 2017 | $159,000 | +51.4% | 78,210 | -1.0% | 0.00% | – |
| Q3 2017 | $105,000 | -19.2% | 79,010 | -4.5% | 0.00% | – |
| Q2 2017 | $130,000 | -73.1% | 82,720 | -77.3% | 0.00% | – |
| Q2 2016 | $484,000 | -94.6% | 363,835 | -78.4% | 0.00% | -100.0% |
| Q1 2016 | $8,891,000 | +64.4% | 1,686,626 | +144.8% | 0.01% | +66.7% |
| Q4 2015 | $5,408,000 | +94.9% | 688,888 | +109.8% | 0.00% | +50.0% |
| Q3 2015 | $2,775,000 | -6.5% | 328,424 | +48.5% | 0.00% | 0.0% |
| Q3 2014 | $2,968,000 | -45.2% | 221,198 | -48.0% | 0.00% | -33.3% |
| Q2 2014 | $5,415,000 | -41.4% | 425,002 | -45.3% | 0.00% | -50.0% |
| Q1 2014 | $9,241,000 | -16.4% | 777,357 | -2.9% | 0.01% | -14.3% |
| Q4 2013 | $11,057,000 | -34.6% | 800,613 | -17.3% | 0.01% | -36.4% |
| Q3 2013 | $16,896,000 | +42.2% | 968,283 | +32.4% | 0.01% | +37.5% |
| Q2 2013 | $11,882,000 | – | 731,252 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 9,766,508 | $19,826,000 | 2.39% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,286,032 | $2,610,000 | 0.07% |
| Clear Harbor Asset Management, LLC | 153,800 | $312,000 | 0.06% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 219,652 | $445,000 | 0.03% |
| Rock Springs Capital Management LP | 270,000 | $548,000 | 0.02% |
| Alambic Investment Management, L.P. | 77,665 | $158,000 | 0.02% |
| Marshall Wace North America L.P. | 1,173,515 | $2,382,000 | 0.01% |
| Baker Brothers Advisors | 580,400 | $1,178,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 459,000 | $932,000 | 0.01% |
| Intellectus Partners, LLC | 13,000 | $26,000 | 0.01% |